Results 251 to 260 of about 11,179 (269)
Some of the next articles are maybe not open access.
The global preclinical antibacterial pipeline
Nature Reviews Microbiology, 2019Ursula Theuretzbacher +2 more
exaly
DIFFERENCE BETWEEN TRADITIONAL COSTING AND ACTIVITY BASED COSTING
2019YANIK, RAMAZAN +2 more
openaire +2 more sources
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
Nature Reviews Drug Discovery, 2014Vladimir P Torchilin
exaly
Induced protein degradation: an emerging drug discovery paradigm
Nature Reviews Drug Discovery, 2016Craig M Crews
exaly
Cancer immunoediting and resistance to T cell-based immunotherapy
Nature Reviews Clinical Oncology, 2018Jake S O'donnell +2 more
exaly
Understanding, recognizing, and managing toxicities of targeted anticancer therapies
Ca-A Cancer Journal for Clinicians, 2013exaly
Minimizing non-radiative recombination losses in perovskite solar cells
Nature Reviews Materials, 2019Deying Luo, Rui Su, Wei Zhang
exaly
Filling a gap in traditional transaction cost economics:
International Journal of Production Economics, 2002K. Blomqvist +2 more
openaire +1 more source